Publication:
Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?

Simple item page
dc.contributor.authorVerd, Sergio
dc.contributor.authorVerd, Mateo
dc.date.accessioned2024-09-18T06:42:26Z
dc.date.available2024-09-18T06:42:26Z
dc.date.issued2021-01-26
dc.format.page625295es_ES
dc.format.volume11es_ES
dc.identifier.citationVerd S, Verd M. Commentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness? [editorial]. Front Pharmacol. 2021 Jan 26;11:625295.en
dc.identifier.doi10.3389/fphar.2020.625295
dc.identifier.issn1663-9812
dc.identifier.journalFrontiers in Pharmacologyes_ES
dc.identifier.otherhttp://hdl.handle.net/20.500.13003/9109
dc.identifier.pubmedID33574761es_ES
dc.identifier.puiL634131245
dc.identifier.scopus2-s2.0-85101030519
dc.identifier.urihttps://hdl.handle.net/20.500.12105/23201
dc.identifier.wos615977200001
dc.language.isoengen
dc.publisherFrontiers Media
dc.relation.publisherversionhttps://dx.doi.org/10.3389/fphar.2020.625295en
dc.rights.accessRightsopen accessen
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectMetabolic syndrome
dc.subjectObesity
dc.subjectDown syndrome
dc.subjectOxidative stress
dc.subjectHyperthyroidism
dc.subjectGlutathione
dc.titleCommentary: Paracetamol-Induced Glutathione Consumption: Is There a Link With Severe COVID-19 Illness?en
dc.typeeditorialen
dspace.entity.typePublication
relation.isPublisherOfPublication9f9fa5ea-093b-43d8-bf2c-5bd65d08a802
relation.isPublisherOfPublication.latestForDiscovery9f9fa5ea-093b-43d8-bf2c-5bd65d08a802

Files

Collections

IdisBa - Instituto de Investigación Sanitaria Illes Balears (Baleares)